Login / Signup

Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease.

Denitza P BlagevDave S CollingridgeSusan ReaKyle A CareyRichard A MularskiSiyang ZengMehrdad ArjomandiValerie G Press
Published in: BMJ open respiratory research (2021)
The LIVE Score identifies three major clinically actionable cohorts: a stable low-risk LIVE group, an unstable high-risk LIVE group with high mortality rates, and a medium-risk LIVE group. These observations further our understanding of how existing data used to calculate the LIVE Score may target interventions across risk cohorts of patients with COPD in a health system.
Keyphrases